跳至主要内容
临床试验/JPRN-UMIN000021516
JPRN-UMIN000021516已完成未知

Effect of saxagliptin on endothelial function in patients with type 2 diabetes; Multi-center clinical trial - Effect of saxagliptin on endothelial function in patients with type 2 diabetes; Multi-center clinical trial

Medical Center for Translational and Clinical Research, Hiroshima University Hospital0 个研究点目标入组 40 人开始时间: 2016年3月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Has history of hypersensitivity to ipragliflozin or any other excipient of saxagliptin 2. Has history of administration of DPP-4 inhibitor within 4 weeks before initiation of the study 3.patient with insulin dependent diabetes mellitus 4. Has history of myocardial infarction, angina, cerebral infarction, intracranial hemorrhage, subarachnoid hemorrhage, transient ischemic attacks within 3 months before initiation of the study 5. patient with ASO 6. With severe renal dysfunction (eGRF <50 mL/min or patient undergoing artificial dialysis) 7. Has history of severe ketosis, diabetic coma, or precoma within 6 months 8. Has history of cancer, severe infection 9. Pregnant, possibly pregnant, planned to become pregnant or nursing women 10. Are considered not eligible for the study by the attending doctor due to other reasons

研究者

发起方
Medical Center for Translational and Clinical Research, Hiroshima University Hospital

相似试验